In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity ...

Triple-negative breast cancer does not respond to targeted breast cancer treatments, which limits treatment to primarily chemotherapy for now.

Berger for the latest episode of the “Cancer Horizons” podcast to discuss frontline treatment options for patients with ...

For Chase Johnson, an unexpected change in her dog’s behavior became a life-altering warning. At 31, Johnson noticed her ...

Datopotamab deruxtecan received FDA approval for HR+/HER2– breast cancer, improving progression-free survival and overall ...

New research shows that women living near Superfund sites are more likely to develop aggressive and metastatic breast cancers ...

Although it is commonly known that breast cancer is classified into different stages, many may be unaware that there are also different types of breast cancer. One rare form of the disease is ...

Groundbreaking research suggests that Triple-Negative Breast Cancer is "addicted" to lipids, prompting experts to warn ...

Triple negative breast cancer (TNBC) represents approximately 10-15% of all breast cancer diagnoses but accounts for a disproportionately high percentage of breast cancer deaths. What sets this ...

Triple Negative Breast Cancer (TNBC) is one of the most aggresive types of breast cancer. It’s the kind of breast cancer that doesn’t have estrogen receptors, progesterone receptors, and human ...

Who knew that fighting breast cancer for the third time in seven years would reveal my purpose in life. I have never felt better about my life than now. My mantra each morning when I wake up, during ...

Please provide your email address to receive an email when new articles are posted on . African American women with triple-negative breast cancer had similar tumor mutational landscape as white women ...